gold has been researched along with titanocene in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amrouche, H; Bertrand, B; Casini, A; Comte, V; Eymin, MJ; Groessl, M; Harvey, JA; Harvey, PD; Le Gendre, P; Picquet, M; Richard, P; Wenzel, M; Zava, O | 1 |
Aliaga-Lavrijsen, M; Contel, M; Cornejo, MA; Curado, N; Giménez, N; Jarzecki, AA; Miachin, K | 1 |
2 other study(ies) available for gold and titanocene
Article | Year |
---|---|
Multinuclear cytotoxic metallodrugs: physicochemical characterization and biological properties of novel heteronuclear gold-titanium complexes.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; Gold; Humans; Luminescence; Magnetic Resonance Spectroscopy; Models, Molecular; Organometallic Compounds; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Structure-Activity Relationship; Titanium | 2011 |
Preparation of Titanocene-Gold Compounds Based on Highly Active Gold(I)-N-Heterocyclic Carbene Anticancer Agents: Preliminary in vitro Studies in Renal and Prostate Cancer Cell Lines.
Topics: Antineoplastic Agents; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Coordination Complexes; Density Functional Theory; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gold; Heterocyclic Compounds; Humans; Methane; Molecular Structure; Organometallic Compounds; Structure-Activity Relationship | 2019 |